KIMBERLY ANN WALL NP
Prescription History 1689310849
Nurse Practitioner - Gerontology in Melrose, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for KIMBERLY ANN WALL NP, an active Gerontology specialist practicing in Melrose, MA. Our medical registry currently tracks 18 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 829 documented patient claims. Among these therapy options, the most frequently utilized medication is Trelegy Ellipta, which accounts for 148 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 148 | $851.51 | ▲ More than typical |
About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. In 2024, this provider wrote 148 Medicare prescriptions for Trelegy Ellipta, about 2.3 times the volume of the typical Massachusetts prescriber of this medication (63). Medicare paid an average of $851.51 per fill, versus $812.87 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 198 30-Day Fills standardized to 30-day supplies 5,940 Days of Medication total across all patients in 2024 | |||
| Albuterol Sulfate HfaAlbuterol Sulfate | 129 | $35.94 | ▲ More than typical |
About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is also used to prevent asthma brought on by exercise. It is a quick-relief drug. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2024, this provider wrote 129 Medicare prescriptions for Albuterol Sulfate Hfa, about 2.2 times the volume of the typical Massachusetts prescriber of this medication (57.7). Medicare paid an average of $35.94 per fill, versus $31.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 167.8 30-Day Fills standardized to 30-day supplies 4,185 Days of Medication total across all patients in 2024 | |||
| Prednisone | 97 | $4.90 | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 97 Medicare prescriptions for Prednisone, about 2.2 times the volume of the typical Massachusetts prescriber of this medication (44.4). Medicare paid an average of $4.90 per fill, versus $4.60 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 111 30-Day Fills standardized to 30-day supplies 1,873 Days of Medication total across all patients in 2024 | |||
| Azithromycin | 76 | $5.84 | ▲ More than typical |
About Azithromycin: Azithromycin is used to treat a wide variety of bacterial infections. Show more ▾ It is a macrolide-type antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2024, this provider wrote 76 Medicare prescriptions for Azithromycin, about 2.6 times the volume of the typical Massachusetts prescriber of this medication (29.7). Medicare paid an average of $5.84 per fill, versus $5.64 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 88.9 30-Day Fills standardized to 30-day supplies 1,403 Days of Medication total across all patients in 2024 | |||
| Roflumilast | 64 | $66.78▼ below MA avg | ▲ More than typical |
About Roflumilast: Roflumilast is used to control and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis). Show more ▾ It should be used along with other medications (bronchodilators such as salmeterol, ipratropium) to treat COPD. It works by reducing the irritation and swelling of the airways. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath or wheezing. If sudden breathing problems occur, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 64 Medicare prescriptions for Roflumilast, about 1.7 times the volume of the typical Massachusetts prescriber of this medication (36.8). Medicare paid an average of $66.78 per fill, versus $94.84 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 94.9 30-Day Fills standardized to 30-day supplies 2,824 Days of Medication total across all patients in 2024 | |||
| Incruse ElliptaUmeclidinium Bromide | 64 | $438.76 | ▲ More than typical |
About Incruse Ellipta: Umeclidinium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. Muscarinic Antagonist. In 2024, this provider wrote 64 Medicare prescriptions for Incruse Ellipta, about 2.1 times the volume of the typical Massachusetts prescriber of this medication (30). Medicare paid an average of $438.76 per fill, versus $431.52 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 82 30-Day Fills standardized to 30-day supplies 2,460 Days of Medication total across all patients in 2024 | |||
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 30 | $279.41 | ≈ Typical |
About Budesonide-Formoterol Fumarate: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. In 2024, this provider wrote 30 Medicare prescriptions for Budesonide-Formoterol Fumarate, about 1.2 times the volume of the typical Massachusetts prescriber of this medication (24.4). Medicare paid an average of $279.41 per fill, versus $248.89 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2024 | |||
| Montelukast Sodium | 28 | $10.61▼ below MA avg | ▼ Less than typical |
About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾ It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways. A leukotriene D4 receptor antagonist. In 2024, this provider wrote 28 Medicare prescriptions for Montelukast Sodium, about 72% of the volume of the typical Massachusetts prescriber of this medication (38.9). Medicare paid an average of $10.61 per fill, versus $15.71 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 65.3 30-Day Fills standardized to 30-day supplies 1,956 Days of Medication total across all patients in 2024 | |||
| Breo ElliptaFluticasone/Vilanterol | 26 | $701.41 | ▼ Less than typical |
About Breo Ellipta: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾ This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 26 Medicare prescriptions for Breo Ellipta, about 72% of the volume of the typical Massachusetts prescriber of this medication (36.3). Medicare paid an average of $701.41 per fill, versus $493.68 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 49 30-Day Fills standardized to 30-day supplies 1,470 Days of Medication total across all patients in 2024 | |||
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $1,030.83 | ▼ Less than typical |
About Breztri Aerosphere: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you maintain your normal activities and decreases time lost from work or school. This inhaler contains 3 medications: budesonide, glycopyrrolate, and formoterol. Budesonide works by reducing the irritation and swelling of the airways. Budesonide belongs to a class of drugs known as corticosteroids. Glycopyrrolate and formoterol work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Glycopyrrolate belongs to a class of drugs known as anticholinergics. Formoterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This medication is not approved to treat asthma. In 2024, this provider wrote 23 Medicare prescriptions for Breztri Aerosphere, about half the volume of the typical Massachusetts prescriber of this medication (46.3). Medicare paid an average of $1,030.83 per fill, versus $775.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39 30-Day Fills standardized to 30-day supplies 1,170 Days of Medication total across all patients in 2024 | |||
| Ventolin HfaAlbuterol Sulfate | 23 | $115.66 | ▼ Less than typical |
About Ventolin Hfa: Albuterol (also known as salbutamol) is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is also used to prevent asthma brought on by exercise. It is a quick-relief drug. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2024, this provider wrote 23 Medicare prescriptions for Ventolin Hfa, about 72% of the volume of the typical Massachusetts prescriber of this medication (31.8). Medicare paid an average of $115.66 per fill, versus $66.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32.7 30-Day Fills standardized to 30-day supplies 898 Days of Medication total across all patients in 2024 | |||
| Wixela InhubFluticasone Propion/Salmeterol | 21 | $128.45 | ≈ Typical |
About Wixela Inhub: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 21 Medicare prescriptions for Wixela Inhub, about 78% of the volume of the typical Massachusetts prescriber of this medication (26.8). Medicare paid an average of $128.45 per fill, versus $126.95 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33 30-Day Fills standardized to 30-day supplies 990 Days of Medication total across all patients in 2024 | |||
| Doxycycline Hyclate | 20 | $7.76▼ below MA avg | ▼ Less than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 20 Medicare prescriptions for Doxycycline Hyclate, about 69% of the volume of the typical Massachusetts prescriber of this medication (28.8). Medicare paid an average of $7.76 per fill, versus $11.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 20 30-Day Fills standardized to 30-day supplies 149 Days of Medication total across all patients in 2024 | |||
| Spiriva RespimatTiotropium Bromide | 19 | $933.10 | ▼ Less than typical |
About Spiriva Respimat: Tiotropium is used to treat lung diseases such as asthma and COPD (bronchitis, emphysema). Show more ▾ It must be used regularly to prevent wheezing and shortness of breath. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 19 Medicare prescriptions for Spiriva Respimat, about 60% of the volume of the typical Massachusetts prescriber of this medication (31.5). Medicare paid an average of $933.10 per fill, versus $671.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2024 | |||
| Dupixent PenDupilumab | 18 | $3,690.44▼ below MA avg | ▼ Less than typical |
About Dupixent Pen: This medication is used to treat certain skin conditions (eczema, prurigo nodularis) and a certain esophagus problem (eosinophilic esophagitis). Show more ▾ It is also used along with other medications to help control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD). In addition, dupilumab may be used to reduce symptoms caused by nasal polyps and the long-term swelling of the sinuses and nasal passage (chronic rhinosinusitis with nasal polyposis). Dupilumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking certain natural proteins in your body (interleukin-4 and interleukin-13) that may cause inflammation and swelling. This medication should not be used to relieve sudden shortness of breath or wheezing. If sudden breathing problems occur, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. Targets the alpha subunit of interleukin-4 receptor. In 2024, this provider wrote 18 Medicare prescriptions for Dupixent Pen, about half the volume of the typical Massachusetts prescriber of this medication (31.2). Medicare paid an average of $3,690.44 per fill, versus $3,947.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 18 30-Day Fills standardized to 30-day supplies 462 Days of Medication total across all patients in 2024 | |||
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $180.47 | ▼ Less than typical |
About Fluticasone-Salmeterol: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 17 Medicare prescriptions for Fluticasone-Salmeterol, about 74% of the volume of the typical Massachusetts prescriber of this medication (22.8). Medicare paid an average of $180.47 per fill, versus $149.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39 30-Day Fills standardized to 30-day supplies 1,170 Days of Medication total across all patients in 2024 | |||
| SymbicortBudesonide/Formoterol Fumarate | 14 | $320.14 | ▼ Less than typical |
About Symbicort: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 14 Medicare prescriptions for Symbicort, about half the volume of the typical Massachusetts prescriber of this medication (25.3). Medicare paid an average of $320.14 per fill, versus $291.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| Combivent RespimatIpratropium/Albuterol Sulfate | 12 | $469.42▼ below MA avg | ▼ Less than typical |
About Combivent Respimat: This product is used to treat and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾ This product contains 2 medications: ipratropium and albuterol (also known as salbutamol). Both drugs work by relaxing the muscles around the airways so that the airways open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A combined pharmaceutical preparation of Ipratropium Bromide and Albuterol Sulfate that is used to treat the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 12 Medicare prescriptions for Combivent Respimat, about half the volume of the typical Massachusetts prescriber of this medication (20.9). Medicare paid an average of $469.42 per fill, versus $591.83 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 12 30-Day Fills standardized to 30-day supplies 318 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for KIMBERLY ANN WALL NP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Gerontology prescribing approach at this Melrose, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
